Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YQD + Lactobacillus in Slow Transit Constipation
NCT07757061Completed
- Sponsor
- First People's Hospital of Lin'an District, Hangzhou
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of live double combined lactobacillus in Slow-transit constipation (STC) (4 arms), sponsored by First People's Hospital of Lin'an District, Hangzhou. Primary endpoint: Constipation Severity Score at 8 weeks. Started Jan 2025; status: completed.
02
Drugs
live double combined lactobacillus
03
Conditions
Slow-transit constipation (STC)
Beyond the preview
Go deeper on NCT07757061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07757061.